In a major breakthrough for men’s health, Ohh-Med Medical has announced a significant milestone for its flagship product, Vertica, which helps improve erectile function. The cutting-edge device recently achieved full reimbursement approval from a major national insurance company in Germany, marking a crucial step toward broader accessibility for men seeking effective treatment for erectile dysfunction (ED). Additionally, the company has received approval from Australia’s Therapeutic Goods Administration (TGA), allowing Vertica to enter the Australian market.
Insurance Reimbursement Sets a Game-Changing Precedent in Germany
Ohh-Med Medical’s innovative Vertica device made headlines when it became eligible for reimbursement in Germany, a first for the company. After persistent efforts, the insurance company approved the request after three attempts, according to Farina Kaasen, product specialist for Kaasen Medical, Vertica’s distributor in Germany. “This case was approved after a lot of hard work, and we hope it sets a precedent for other insurance companies to follow,” Kaasen shared.
This milestone brings hope to the many men seeking a non-invasive, clinically proven solution for ED, as insurance coverage would make the device more accessible to a wider range of patients.
TGA Approval Opens New Doors in Australia
Along with this exciting development in Germany, Vertica also received approval from Australia’s Therapeutic Goods Administration (TGA), allowing the product to be marketed throughout the country. Vertica will be distributed by Harp Upson Enterprises, based in Melbourne.
Lisa Harp, CEO of Harp Upson Enterprises, expressed her optimism about the device’s reception. “There is already high interest in Vertica, and we are ready to launch it in Australia. The competition is tough, but we are confident that Vertica’s results are superior and long-lasting,” Harp said.
A Revolutionary Approach to Treating Erectile Dysfunction
What sets Vertica apart from other ED treatments is its innovative use of radiofrequency technology to target the root cause of the issue: weakened erectile tissue. By improving the blood flow and enhancing the tissues responsible for trapping blood in the penis during an erection, Vertica offers a non-invasive solution that restores natural erectile function without the need for medication or invasive treatments.
A clinical study published in the International Journal of Impotence Research found an 85% success rate for Vertica users, with many experiencing improvements after just four weeks of use. The results can last up to six months, offering long-term relief and improved performance.
“Vertica is especially effective for men suffering from erectile dysfunction, but all men can benefit from the treatment,” said Daniel Lischinsky, founder and CEO of Ohh-Med Medical. “It’s exciting to see so many men regain their confidence and experience fulfilling relationships thanks to Vertica.”
A Bright Future for Men’s Health
Founded in 2017, Ohh-Med Medical has quickly established itself as a leader in technology-based medical solutions for urology. Vertica, the company’s flagship product, has already improved the lives of over 5,000 men worldwide, offering an effective, non-invasive treatment for erectile dysfunction, Peyronie’s disease, and post-prostatectomy rehabilitation.
With its recent insurance reimbursement approval in Germany and TGA approval in Australia, Vertica is set to become a global leader in men’s health solutions. As more men discover the benefits of this groundbreaking device, the future of ED treatment looks brighter than ever.
For more information on Vertica and Ohh-Med Medical’s innovative treatments, visit vertica-labs.com.